12 Best Mid-Cap Stocks with Huge Upside Potential

Page 12 of 12

1. Moderna, Inc. (NASDAQ:MRNA)

Analyst Upside: 90.95%

Market Capitalization: $9.37 billion

Number of Hedge Fund Holders: 39

Moderna, Inc. (NASDAQ:MRNA) ranks among the best mid-cap stocks with huge upside potential. Moderna, Inc. (NASDAQ:MRNA) reported on August 27 that the US Food and Drug Administration had granted supplementary Biologics License Applications for its 2025-2026 COVID-19 vaccination compositions aimed at the LP.8.1 variant of SARS-CoV-2.

All adults 65 years of age and over, as well as individuals aged 6 months to 64 with at least one underlying disease that raises the risk of severe COVID-19 outcomes, were approved to receive the revised Spikevax vaccination.

Additionally, the updated vaccine composition complies with FDA recommendations that monovalent JN.1 lineage, preferably the LP.8.1 variation, be used in the development of COVID-19 vaccines.

Moderna, Inc. (NASDAQ:MRNA) is a biotechnology company dedicated to the discovery, development, and commercialization of mRNA-based medicines and vaccines. The company received solid recognition for its COVID-19 vaccine, which was one of the first mRNA vaccines to be created and delivered worldwide.

While we acknowledge the potential of MRNA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MRNA and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 12 of 12